Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Administrative law (1)
- Animal drug (1)
- Biologic (1)
- Casebook (1)
- Color additive (1)
-
- Combination product (1)
- Cosmetic (1)
- Dietary supplement (1)
- Drug (1)
- FDA (1)
- FDCA (1)
- FFDCA (1)
- Food (1)
- Food additive (1)
- Food and drug (1)
- HCT/P (1)
- Human tissue (1)
- Medical device (1)
- Medical research (1)
- Pharmaceutical (1)
- Preemption (1)
- Regulation (1)
- Regulatory (1)
- Statutory (1)
- Supplement (1)
- Tobacco product (1)
Articles 1 - 2 of 2
Full-Text Articles in Entire DC Network
Retroviral Protease (Rvp) Ddi2 Is A Viable Alternative For Full-Length (Fl) Ddi2, Ethan Chi
Retroviral Protease (Rvp) Ddi2 Is A Viable Alternative For Full-Length (Fl) Ddi2, Ethan Chi
Undergraduate Research Symposium Lightning Talks
Proteasome inhibitors are drugs used to treat multiple myeloma. Currently, three are approved by the FDA.
Food And Drug Regulation: Statutory And Regulatory Supplement (2022 ), Adam I. Muchmore
Food And Drug Regulation: Statutory And Regulatory Supplement (2022 ), Adam I. Muchmore
Books
This Statutory and Regulatory Supplement is intended for use with its companion casebook, Food and Drug Regulation: A Statutory Approach (2021). This is not a traditional statutory supplement. Instead, it contains selected, aggressively edited provisions of the Federal Food, Drug and Cosmetic Act (FFDCA), related statutes, and the Code of Federal Regulations. The Supplement includes all provisions assigned as reading in the casebook, as well as a few additional provisions that some professors may wish to cover. The excerpts are designed to be teachable rather than comprehensive.